Ventyx Biosciences (VTYX) Competitors

Ventyx Biosciences (NASDAQ:VTYX) and Upstream Bio (NASDAQ:UPB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Is VTYX or UPB more profitable?

Upstream Bio's return on equity of 0.00% beat Ventyx Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ventyx Biosciences	N/A	-54.94%	-50.01%
Upstream Bio	N/A	N/A	N/A

Does the MarketBeat Community believe in VTYX or UPB?

Ventyx Biosciences received 27 more outperform votes than Upstream Bio when rated by MarketBeat users. However, 80.00% of users gave Upstream Bio an outperform vote while only 46.97% of users gave Ventyx Biosciences an outperform vote.

Company	Underperform	Outperform
Ventyx Biosciences	Outperform Votes 31 46.97%	Underperform Votes 35 53.03%
Upstream Bio	Outperform Votes 4 80.00%	Underperform Votes 1 20.00%

Which has preferable earnings and valuation, VTYX or UPB?

Upstream Bio has higher revenue and earnings than Ventyx Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ventyx Biosciences	N/A	N/A	-$192.96M	-$1.75	-1.49
Upstream Bio	$2.30M	267.59	N/A	N/A	N/A

Does the media refer more to VTYX or UPB?

In the previous week, Upstream Bio had 3 more articles in the media than Ventyx Biosciences. MarketBeat recorded 5 mentions for Upstream Bio and 2 mentions for Ventyx Biosciences. Ventyx Biosciences' average media sentiment score of 1.61 beat Upstream Bio's score of 0.73 indicating that Ventyx Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ventyx Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Upstream Bio	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals hold more shares of VTYX or UPB?

97.9% of Ventyx Biosciences shares are held by institutional investors. 14.5% of Ventyx Biosciences shares are held by company insiders. Comparatively, 13.6% of Upstream Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts rate VTYX or UPB?

Ventyx Biosciences presently has a consensus price target of $10.00, suggesting a potential upside of 283.88%. Upstream Bio has a consensus price target of $56.50, suggesting a potential upside of 394.70%. Given Upstream Bio's stronger consensus rating and higher probable upside, analysts plainly believe Upstream Bio is more favorable than Ventyx Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ventyx Biosciences	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Upstream Bio	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Upstream Bio beats Ventyx Biosciences on 8 of the 12 factors compared between the two stocks.